Pepbloc FG



Formulation : H-Gly-Pro-Arg-Pro-OH; AcOH
MW(Da) : 485.5
Pepbloc FG binds to fibrinogen to inhibit polymerization of the fibrin network, thereby disrupting the mechanical properties of the clot.
Inhibits fibrin formation and turbidity of the fibrin network.

Reference | Presentation | Packaging | |
---|---|---|---|
6-INH-FG-5 | Vial | 3 x 50 mg |